Hepatitis C Anti-Viral Therapy Guidance Review 2018

Module number
Date presented
October 23, 2018 
CE Credit

On Tuesday, October 23rd, Dr. Ayse Aytaman of the Veterans Health Administation presented on: “Hepatitis C Anti-Viral Therapy Guidance Review 2018”

Presenter Bio:
Dr. Ayse Aytaman earned her medical degree from the University of Vienna, where she studied with a full scholarship from the Austrian Ministry of Education. After her residency and fellowship in gastroenterology and hepatology at SUNY Health Science Center at Brooklyn, she joined the faculty at VA New York Harbor HCS in Brooklyn. She created the first multidisciplinary viral hepatitis team in 1999 with inclusion of pharmD and liver psychology in the VA system. In 2012, with a grant from VA Public Health, she established the first multi-facility and multidisciplinary, VISN-wide hepatocellular carcinoma team and SCAN ECHO liver cancer tumor board in the nation, utilizing heavily telehealth/virtual telemedicine technology. This year, she launched the national VA Liver Cancer Team.
Dr. Aytaman is also organizes the yearly  national liver cancer summits since 2012 for the VA providers.
Dr. Aytaman’s clinical research interest areas are epidemiology and outcomes research in advanced liver diseases, hepatocellular carcinoma, system-based performance improvement in chronic and advanced liver diseases and pre- and post-transplant hepatitis C therapy.
Dr. Aytaman is also the regional governor of American College of Gastroenterology.

Access the slides here